tiprankstipranks
Novabay Pharmaceuticals (NBY)
:NBY
US Market

NovaBay Pharma (NBY) Income Statement

Compare
648 Followers

NovaBay Pharma Income Statement

Last quarter (Q3 2024), NovaBay Pharma's total revenue was $2.44M, a decrease of -25.01% from the same quarter last year. In Q3, NovaBay Pharma's net income was $-1.21M. See NovaBay Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 14.73M$ 14.40M$ 8.42M$ 9.93M$ 6.60M
Gross Profit
$ 7.89M$ 7.78M$ 5.64M$ 5.96M$ 4.86M
Operating Expenses
$ 12.90M$ 15.46M$ 14.51M$ 12.39M$ 14.26M
Depreciation and Amortization
$ 203.00K$ 483.00K$ 119.00K$ 51.00K$ 65.00K
EBITDA
$ -4.80M$ -7.20M$ -8.74M$ -6.38M$ -9.34M
Operating Income
$ -5.00M$ -7.68M$ -8.86M$ -6.43M$ -9.40M
Other Income/Expenses
$ -4.64M$ -2.78M$ 3.04M$ -4.61M$ -252.00K
Pretax Income
$ -9.64M$ -10.61M$ -5.82M$ -11.03M$ -9.65M
Net Income
$ -9.64M$ -16.27M$ -6.56M$ -11.04M$ -10.49M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -138.65$ -353.59$ -184.09$ -385.53$ -593.63
Diluted EPS
$ -138.65$ -353.59$ -184.09$ -385.53$ -593.63
Weighted Average Shares Outstanding
120.43K 30.00K 31.64K 28.63K 16.27K
Weighted Average Shares Outstanding (Diluted)
120.43K 46.00K 35.63K 28.63K 17.67K
Currency in USD

NovaBay Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis